Product Program year 2024 Source: CMS Open Payments

iDose TR

Device Glaucoma

Open in the dashboard

General payments

$741

7 payments

Research payments

$0

0 payments

Through program year 2024, $741 in general payments and $0 in research payments were reported against iDose TR (Glaucoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $741 7

Breakdown

Who paid General payments · program year 2024
  1. Glaukos Corporation $741 7 payments
Top recipients General payments · program year 2024
  1. Daniel Kim Ophthalmology · Palisades Park, NJ $243 33% · 3 payments
  2. Mary Shatleh Optometrist · Pearland, TX $169 23% · 1 payment
  3. Jennifer Wilcox Optometrist · Spartanburg, SC $161 22% · 1 payment
  4. Thomas Conrod Optometrist · Hamden, CT $140 19% · 1 payment
  5. Drew Garwood Optometrist · Saint Joseph, MO $28 4% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Optometrist $497 67% · 4 practitioners
  2. Ophthalmology $243 33% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. New York $243 33% · 1 recipient
  2. Texas $169 23% · 1 recipient
  3. South Carolina $161 22% · 1 recipient
  4. Nebraska $140 19% · 1 recipient
  5. Missouri $28 4% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

7 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record